Serial Problem Solver
Teva to Settle US Opioid Lawsuits for $4.35 Billion | The Jewish Press - JewishPress.com | David Israel | 28 Tammuz 5782 – July 27, 2022 | JewishPress.com
Ambassador views Teva CEO as important player in potential vaccine alliance
Kare Schultz | C-SPAN.org
Teva CEO Kare Schultz on coronavirus treatment and a possible second wave
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | Fierce Pharma
Teva CEO Says Drugmaker Will Fight US Price-Fixing Charges (2)
Parsippany-based Teva reaches $225M opioid settlement with Texas - NJBIZ
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva boss hits out at opioid lawsuits | Financial Times
Running out of time and money, CEO to prioritize getting Teva out of the hole | The Times of Israel
Teva CEO Schultz: 'Proof Is In The Pudding' For US Biosimilars :: Generics Bulletin
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Watch CNBC's full interview with Teva CEO Kåre Schultz
Teva finally nabs a CEO, and it's Lundbeck helmsman—and Novo ex—Kåre Schultz | Fierce Pharma
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Teva sees return to growth after opioid settlement, shares jump | Reuters
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - BNN Bloomberg
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Teva poaches Lundbeck's Schultz as new CEO - PMLiVE
Teva Names Kare Schultz as President and Chief Executive Officer - Pharmaceutical Processing World
Where is Kåre Schultz? | Ctech
Teva Appoints Lundbeck's Schultz as CEO | Ctech
